Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy-Reference-Cited by-同舟云学术

Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy

Author:

Kulkarni Ashish¹²³,Natarajan Siva Kumar³,Chandrasekar Vineethkrishna³,Pandey Prithvi Raj⁴,Sengupta Shiladitya¹²³⁵

Affiliation:

1. Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, United States

2. Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts 02139, United States

3. Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts 02115, United States

4. India Innovation Research Center and Invictus Oncology, New Delhi 110092, India

5. Dana Farber Cancer Institute, Boston, Massachusetts 02115, United States

Funder

National Cancer Institute

Indo-US Science and Technology Forum

Congressionally Directed Medical Research Programs

American Lung Association

U.S. Department of Defense

American Cancer Society

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

Reference52 articles.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献